Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

127.64 -1.08 (-0.84%)

Streaming Delayed Price Updated: 10:35 AM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

35 36 Next >

Latin America’s Next-Generation Sequencing (NGS) Market Set to Reach $597.2 Million by 2034, Driven by Cancer Genomics and Personalized Medicine

August 07, 2025

Via AB Newswire

Illumina Settles With DOJ, Veterans To End Whistleblower Lawsuit ↗

August 06, 2025

Illumina will pay $9.8 million to settle allegations it sold genomic systems with cybersecurity flaws to U.S. agencies. A whistleblower will receive $1.9 million.

Via Benzinga

Topics Whistleblower

PacBio (PACB) Q2 Earnings Report Preview: What To Look For

August 05, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday afternoon. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence World Trade

Earnings To Watch: 10x Genomics (TXG) Reports Q2 Results Tomorrow

August 05, 2025

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting results this Thursday after market hours. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence Economy World Trade

What Does the Market Think About Illumina? ↗

August 04, 2025

Via Benzinga

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Illumina (ILMN) Q2 2025 Earnings Call Transcript ↗

August 03, 2025

Via The Motley Fool

Topics Earnings

Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion ↗

August 02, 2025

Cathie Wood-led Ark Invest made significant trades in COIN, ROKU, ILMN, and BMNR. They also bought PD and SOFI, sold KTOS and RBLX.

Via Benzinga

Illumina (ILMN) Q2 EPS Jumps 9% ↗

August 01, 2025

Via The Motley Fool

Why Illumina (ILMN) Shares Are Falling Today

August 01, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) fell 6.1% in the afternoon session as investors reacted to its second-quarter earnings report, where a year-over-year revenue decline overshadowed...

Via StockStory

Topics Artificial Intelligence World Trade

These Analysts Boost Their Forecasts On Illumina Following Upbeat Results ↗

August 01, 2025

Via Benzinga

Illumina: A 5.2 Rating Amid Challenges and Opportunities ↗

July 31, 2025

Via The Motley Fool

Illumina Inc (NASDAQ:ILMN) Q2 2025 Earnings: Mixed Results with Revenue Miss and EPS Beat ↗

July 31, 2025

Illumina's Q2 2025 earnings show mixed results: revenue missed estimates at $1.059B (-3% YoY), but EPS beat at $1.19. Shares dipped 1.18% post-report.

Via Chartmill

Illumina (NASDAQ:ILMN) Surprises With Q2 Sales

July 31, 2025

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 3% year on year to $1.06 billion. Its non-GAAP profit of $0.36 per share was 64.4% below...

Via StockStory

Illumina (ILMN) To Report Earnings Tomorrow: Here Is What To Expect

July 29, 2025

Genomics company Illumina (NASDAQ:ILMN) will be reporting earnings this Thursday afternoon. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

Illumina (ILMN) Stock Is Up, What You Need To Know

July 28, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) jumped 3.7% in the pre-market session after analysts at Robert W. Baird increased their price target on the life sciences company's stock to $105.00....

Via StockStory

Topics Artificial Intelligence

12 Analysts Assess Illumina: What You Need To Know ↗

July 28, 2025

Via Benzinga

1 Profitable Stock with Exciting Potential and 2 We Question

July 21, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Illumina Stock: What Went Wrong And Why It's Best To Stay Away ↗

July 17, 2025

According to the Adhishthana Principles, Illumina stock may remain under pressure for over 18 years — here's why.

Via Benzinga

Why Illumina (ILMN) Shares Are Falling Today

July 09, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) fell 4.2% in the morning session after a Citi analyst downgraded the stock to 'Sell' from 'Neutral' and lowered the price target.

Via StockStory

Topics Government World Trade

Where Illumina Stands With Analysts ↗

July 08, 2025

Via Benzinga

Illumina (ILMN) Stock Trades Down, Here Is Why

July 07, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.6% in the afternoon session after the major indices pulled back (Nasdaq -0.8%, S&P 500 -0.77%), largely due to escalating concerns surrounding...

Via StockStory

Topics Artificial Intelligence Government Stocks

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

July 07, 2025

From iRhythm

Via GlobeNewswire

5 Must-Read Analyst Questions From Illumina’s Q1 Earnings Call

July 03, 2025

Illumina’s first quarter results reflected ongoing challenges in the global genomics market, as the company’s performance fell short of market expectations, prompting a negative reaction from...

Via StockStory

Topics Earnings World Trade

“Mag 7 Undercard Movers: IBO, SNYR, CTOR, PNPN.V, LAB – Breakthroughs in Military Defense, Tech, Medical & Healthcare Fuel Market Buzz”

June 23, 2025

Via AB Newswire

Topics Artificial Intelligence

SomaLogic Acquisition Marks Next Step In Illumina's Advanced Biomarker Push ↗

June 23, 2025

Illumina will acquire SomaLogic to expand in proteomics, adding new revenue streams and accelerating tech development in multiomics.

Via Benzinga

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Brush Off

June 20, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

Topics Energy

3 Reasons ILMN is Risky and 1 Stock to Buy Instead

June 18, 2025

What a brutal six months it’s been for Illumina. The stock has dropped 33.6% and now trades at $89.03, rattling many shareholders. This may have investors wondering how to approach the situation.

Via StockStory

Retail Investors Flock To Incyte As Drug Data, Qiagen Deal Fuel Optimism ↗

June 16, 2025

Stifel also upgraded the stock to ‘Buy’ with a $107 price target.

Via Stocktwits

Datadog To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

June 11, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.